September 16, 2025
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
Todayās edition is brought to you by us - THC Group. We advise leading companies at the intersection of cannabis, hemp, alcohol, and AI. Interested in reaching this audience? Sponsorship opportunities are available - reply to this email to learn more.
House Republicans voted to strip their own presidentās authority on cannabis rescheduling. California regulators moved to permanently ban hemp products with any detectable THC. Maryland courts cleared the way for hemp crackdowns after a two year freeze. Delaware launched a milestone based equity grant program, New York scheduled its first psilocybin hearing, and Verano prepared to move its corporate home from Canada to Nevada. At the same time unions are reshaping the industryās political future with resources that far exceed what cannabis trade groups can deploy.
šļø House GOP blocks Trump on rescheduling
š« California hemp ban takes shape
ā Labor emerges as cannabisās new power broker
Stay informed. Move first.
Start here ā the dayās most important development, decoded for impact.
š What Happened: The GOP-controlled House Appropriations Committee passed a spending bill prohibiting the Justice Department from using federal funds to reschedule cannabis, directly contradicting President Trump's recent statements about considering rescheduling "in the next few weeks." The 34-28 committee vote advanced legislation that would freeze the DEA's ongoing Schedule III review while simultaneously gutting the Rohrabacher-Blumenauer Amendment that has protected state medical marijuana programs from federal interference since 2014. The bill also directs DOJ to investigate potential money laundering schemes involving "Chinese Communist Party-connected marijuana businesses" and allows federal enforcement within 1,000 feet of schools even in legal states. This represents the second consecutive year House Republicans have included anti-rescheduling language in appropriations bills, though last year's version was ultimately stripped from the final legislation.
š” Why It Matters: This creates an unprecedented intra-party conflict where Republican legislators are actively working to constrain their own president's cannabis policy options, revealing fundamental ideological fractures within the GOP on federal reform. The strategic use of must-pass spending legislation as a vehicle for cannabis policy represents a dangerous precedent that could weaponize appropriations processes against any administration's reform efforts, regardless of party control. The simultaneous attack on medical marijuana protections signals a potential return to aggressive federal enforcement against state programs, threatening the regulatory certainty that has enabled $30 billion in annual legal cannabis sales. Most critically, this legislative chaos ensures continued regulatory uncertainty that prevents institutional capital deployment and maintains cannabis companies' competitive disadvantage against illicit operators who benefit from policy confusion.
š§ THC Group Take: Welcome to the cannabis policy circus, where Republicans spend four years promising reform then immediately kneecap their own president's ability to deliver on those promises. The Appropriations Committee essentially told Trump "thanks for the campaign rhetoric, but we'll handle actual policy from here," creating the absurd situation where the same party simultaneously supports and opposes cannabis rescheduling depending on which building you're standing in. This isn't just political dysfunction; it's a masterclass in how Washington's institutional incentives reward obstruction over governance, leaving an entire industry hostage to whatever random appropriations rider some committee chair decides to attach this week. The real winner here is regulatory uncertainty, which continues its undefeated streak as the only consistent element of federal cannabis policy.
Fast-moving headlines, flagged for what matters.
California health officials published proposed rules to permanently ban hemp products containing any detectable THC, codifying Governor Newsom's September 2024 emergency regulations that were imposed through executive action after legislative efforts stalled. The proposal would eliminate 115 businesses and cost nearly 19,000 jobs over five years, with $3.14 billion in lost revenue, according to state estimates. This represents the most aggressive state protection of licensed cannabis markets nationwide, forcing all intoxicating products into California's heavily taxed and regulated dispensary system where hemp companies cannot compete. The real strategic impact lies beyond California: other governors with struggling licensed cannabis markets are watching closely, with Texas Governor Abbott already signaling similar executive action is coming soon, setting up a potential domino effect across major cannabis states. (Cannabis Business Times)
California lawmakers passed Assembly Bill 564 with overwhelming bipartisan support, rolling back the state's cannabis excise tax from 19% to 15% through 2028 after the July increase triggered a 13% drop in taxable sales within just two months. The rare legislative unity (39-1 in Senate, 74-0 in Assembly) signals political recognition that California's tax-heavy approach has failed to capture market share from illicit operators, with legal sales representing only 40% of consumption compared to 60-80% in lower-tax states like Michigan and Colorado. This represents a fundamental policy admission that high taxation doesn't maximize revenue when it drives consumers to untaxed alternatives, providing a template for other overtaxed markets to follow. The quick reversal demonstrates how rapidly cannabis tax policy can shift when politicians face undeniable evidence that their approach is backfiring, offering hope for operators in similarly overtaxed jurisdictions. (SFGate)
Maryland's Appellate Court ruled that hemp-derived delta-8 and delta-10 products "are now and have always been illegal," reversing a lower court injunction that had protected hemp retailers from cannabis licensing requirements since October 2023. The Alcohol, Tobacco and Cannabis Commission immediately issued enforcement warnings to unlicensed businesses selling intoxicating hemp products, declaring they're "subject to criminal prosecution" with fines up to $5,000 and misdemeanor charges. The ruling establishes that only state-licensed cannabis dispensaries can legally sell hemp products containing more than 0.5mg THC per serving, effectively forcing thousands of gas stations, vape shops, and convenience stores to either obtain expensive cannabis licenses or exit the hemp market entirely. This signals the end of the regulatory arbitrage that allowed hemp operators to sell intoxicating products without cannabis industry compliance costs, providing a roadmap other states will likely follow to protect their licensed markets from unregulated competition. (Cannabis Business Times)
Delaware's Office of the Marijuana Commissioner unveiled the Social Equity Financial Assistance (SEFA) Grant Program, providing milestone-based funding to help social equity licensees overcome the structural barriers that have historically limited their participation in cannabis markets. The program targets facility build-out, equipment acquisition, and start-up expenses for individuals who lived in high-enforcement areas or have marijuana conviction histories, addressing the capital gap that often prevents social equity licensees from actually opening businesses. Unlike traditional loan programs or tax incentives, SEFA ties funding to operational milestones, ensuring recipients make tangible progress toward opening rather than simply accessing capital without accountability. This milestone approach solves the persistent problem where social equity programs create license winners who never become operating businesses, offering a replicable framework for states serious about translating equity rhetoric into functioning dispensaries. (Delaware Live)
Assembly Health Committee Chair Amy Paulin scheduled a September 30 hearing on psilocybin's "medicinal value and risks," marking the first formal legislative examination of psychedelics policy since New York's cannabis market surpassed $1 billion in sales. The invite-only witness list hasn't been announced, but Paulin specifically noted FDA's "breakthrough therapy" designation for psilocybin in major depression treatment. With three separate psilocybin bills already filed this session (Paulin's permit-based adult use framework, Senator Fernandez's clinical therapy model, and Assemblymember Rosenthal's broad entheogen legalization), this hearing positions New York to move beyond Oregon and Colorado's cautious therapeutic models toward comprehensive psychedelics policy. The timing signals institutional recognition that mental health innovation requires regulatory sophistication, not just clinical trials. (Marijuana Moment)
Multi-state operator Verano Holdings announced plans to redomicile from British Columbia to Nevada, seeking shareholder approval for what amounts to regulatory arbitrage disguised as corporate housekeeping. The move follows Verano's 2023 listing on Cboe Canada and reflects the uncomfortable reality that Canadian incorporation made sense when U.S. exchanges wouldn't touch cannabis, but now creates unnecessary friction with American institutional investors who prefer domestic entities. Nevada's incorporation laws offer operational flexibility and tax advantages that Delaware can't match for cannabis companies, while positioning Verano for easier capital access when federal reform finally arrives. The real tell: this is about preparation for a world where cannabis companies compete for institutional capital on equal footing with traditional businesses, and foreign incorporation becomes a liability rather than a necessity. (MG Magazine)
The Bank Administration Institute's guidance to financial institutions reveals how cannabis banking has evolved from regulatory taboo to calculated business opportunity, with banks now weighing $160 billion in annual sales potential against reputational risks in their specific markets. The shift from "absolutely not" to "risk-reward analysis" means cannabis companies should expect more banking options but also increased leverage to negotiate competitive fees as institutions compete for quality clients in legal markets. Banks are discovering that enhanced due diligence and compliance costs can be offset by premium pricing and strategic differentiation, particularly in cannabis-concentrated markets like Colorado and California where being the "weed bank" becomes a competitive advantage rather than liability. For cannabis operators, this institutional awakening translates to real opportunities for lending, treasury management, and traditional banking relationships, provided they can demonstrate operational sophistication and creditworthiness that justifies banks' elevated compliance investments. (BAI Banking Strategies)
Bavaria just proved you don't need to repeal cannabis laws to kill them, just suffocate them with building codes. Despite issuing eight cultivation licenses under Germany's Cannabis Act, the CSU government has effectively blocked every single Cannabis Social Club from operating by weaponizing zoning law. The December 2024 directive from Bavaria's Supreme Building Authority requires CSCs to operate only in "special-use zones" that barely exist, forcing clubs like CannabisKultur MainSpessart into years-long rezoning battles costing tens of thousands of euros. When local officials push back, as Bamberg's District Office did by calling the restrictions "disproportionate," Bavaria's regional governments simply issue prohibition orders. This administrative warfare offers other conservative jurisdictions a perfect template: comply with federal law on paper while strangling implementation through local planning requirements. As the German Cannabis Association notes, Bavaria stands alone among German states in requiring such restrictions, creating a masterclass in regulatory nullification that turns licensed operators into casualties of bureaucratic bad faith. (Business of Cannabis)
The deeper pattern behind todayās moves ā and why it matters next.
š§¾Ā Context: The NLRB's 2013 jurisdiction assertion over cannabis businesses launched what amounts to organized labor's most aggressive industry takeover since the 1930s, with the UFCW organizing tens of thousands of workers while spending $12 million annually on political activities and the Teamsters deploying $2.1 million in lobbying firepower. Union organizing exploded during COVID as "essential worker" cannabis employees realized they were risking their health for subpar wages, triggering over 100 facility campaigns across 20 states in three years. Meanwhile, states systematically embedded union power into licensing frameworks: California, New York, New Jersey, and Virginia now require "labor peace agreements" as business prerequisites, essentially making union cooperation a cost of market entry. The agricultural worker exemption creates jurisdictional chaos where your trimmer might have union rights while your grower doesn't, forcing operators into expensive NLRB determinations about basic workforce questions.
šĀ What It Signals: Cannabis companies assumed they could handle labor relations casually, only to discover they need the same high-end legal representation as Amazon and Starbucks when facing sophisticated organizing campaigns backed by million-dollar war chests. Union pension funds managing hundreds of billions suddenly have direct financial stakes in cannabis legalization since their members' livelihoods depend on industry growth, creating political allies with resources that make traditional advocacy groups look like lemonade stands. The workplace safety angle gives unions devastating organizing narratives: cannabis operations face serious hazards from chemical exposure and respiratory irritants, with OSHA violations already causing worker deaths that transform wage disputes into life-and-death workplace protection campaigns. Federal prohibition creates regulatory arbitrage that unions exploit ruthlessly, using state labor peace requirements to bypass traditional NLRB election processes.
š§ Ā THC Group Take: Most cannabis executives are approaching labor relations like it's still 2015, when the biggest HR challenge was finding employees who could pass background checks. The reality check: UFCW and Teamsters aren't just organizing your workforce, they're building the political infrastructure to become cannabis's most powerful federal advocates with lobbying relationships and campaign contributions that dwarf anything industry trade groups can muster. Companies burning resources fighting unions are missing the strategic opportunity staring them in the face. These organizations have genuine incentives to push federal legalization, SAFE Banking, and workplace safety standards that legitimize your entire industry. The smart money recognizes labor peace agreements as strategic partnerships with the only institutions that can deliver the political wins cannabis needs, while providing workforce stability in an industry where talent retention and compliance failures can kill companies overnight.
From the hearing room to the comment section ā weāre watching it all.
š Oregon State researchers tested 12 "magic mushroom" edibles from Portland shops and found exactly zero psilocybin in any of them. What consumers got instead was a cocktail of undisclosed synthetic compounds, caffeine, cannabis extract, and lab-made "syndelics" with unknown safety profiles. The mislabeling epidemic reflects the gap between legitimate psilocybin research advancing through clinical trials and a wild-west retail market capitalizing on psychedelic curiosity without regulatory oversight. (Gizmodo)
š Courts nationwide are wrestling with whether cannabis odor justifies vehicle searches now that legal possession makes smell potentially lawful evidence, creating a patchwork where the same traffic stop could result in different outcomes depending on which state line you're crossing. (Motor Biscuit)
š§¬ Cannabis growers have been composting pharmaceutical gold. South African researchers just discovered rare flavoalkaloids in leaves that cultivation facilities routinely toss, suggesting the industry's waste stream contains unexplored therapeutic compounds that could rival the flower itself. (The Debrief)
š Models vaping live on the runway at Fashion Week while wearing $500 "vape pocket shirts" signals cannabis has officially crossed into cultural mainstream territory where luxury brands queue up for collaborations instead of running from association. (WWD)
š The world's first cannabis-sponsored rugby team is tackling athletic stigma by proving elite performance and plant advocacy aren't mutually exclusive, challenging decades of assumptions about professional sports and substance partnerships. (High Times)